Substance Abuse Treatment Pathways for Employee Groups

员工群体的药物滥用治疗途径

• 批准号: 7477947
• 负责人: ELIZABETH L MERRICK
• 金额: $ 82.35万
• 依托单位: BRANDEIS UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/7477947
• 关键词: Address; Adopted; Affect; Authorization documentation; Awareness; Behavior; Blue Cross; Blue Shield; California; Caring; Characteristics; Complement; Condition; Congresses; Data; Disease; Early Intervention; Eligibility Determination; Employee; Employee Assistance Program (Health Care); Enrollment; Event; Experimental Designs; Failure; Government; Health; Health Benefit; Health Care Costs; Health Insurance; Health Planning; Health Services Accessibility; Incentives; Individual; Insurance; Insurance Carriers; Insurance Coverage; Laws; Marketing; Measures; Medicaid; Medical; Mental Health; Mental Health Services; Methods; Natural experiment; Numbers; Other Resources; Pathway interactions; Pattern; Perception; Persons; Policies; Population; Private Sector; Quality Indicator; Regulation; Research; Research Personnel; Research Project Grants; Resources; Risk; Services; Shapes; Statutes and Laws; Structure; Substance abuse problem; Surveys; Testing; behavioral health; cost; court; emotional abuse; experience; health care service organization; health organization; interest; medical specialties; member; parity; programs; social; willingness

Project 1 - Substance Abuse Treatment Pathways for Employee Groups A key issue in facilitating both initial and continued access to substance abuse treatment is to understand the pathways by which individuals may enter and participate in treatment. In the private sector, employees and their dependents often have multiple options in terms of pathways to specialty treatment, including managed behavioral health care (MBHC) carve-out plans and employee assistance programs (EAPs) - both of which may be provided by the same managed behavioral health organizations (MBHOs). This study offers the opportunity to investigate the interrelationships in utilization patterns and costs among MBHC, EAP, and other resources for substance abuse problems. The study will use claims eligibility, authorization, and initial assessment data from Managed Health Network (MHN), a large national MBHO. In addition, the investigators will conduct a survey of MHN enrollees, including both users and non-users of MHNsubstance abuse treatment services. The study will investigate whether there are differences in substance abuse utilization, costs and enrollee perceptions of care between integrated (EAP/MBHC) and stand-alone component products. Specific questions include: whether there are differences in choice of pathway by enrollee or product characteristics; how utilization patterns and costs vary depending on pathway or product structure; which appears to facilitate earlier intervention; what barriers are perceived by enrollees in regard to potential help resources; how experiences of care differ by pathway; how enrollee awareness and perception of services affects willingness to use services; and whether MBHC and EAP services appear to function as substitutes or complements. The results of this study will be of interest to employers, insurers and policymakers, as they shape policies affecting access to care.

项目1-员工群体的药物滥用治疗途径 促进初始和继续接受药物滥用治疗的关键问题是了解个人可以进入和参加治疗的途径。在私营部门，员工及其家属在特殊治疗途径方面通常具有多种选择，包括托管行为医疗保健（MBHC）制定计划和员工援助计划（EAPS），这两种计划都可以由相同的托管提供 行为健康组织（MBHOS）。这项研究提供了调查MBHC，EAP和其他用于药物滥用问题的资源中利用模式和成本相互关系的机会。该研究将使用来自大型国家MBHO的托管健康网络（MHN）的索赔资格，授权和初步评估数据。此外，调查人员还将对MHN参与者进行调查，包括 MHNSUBSTANCE滥用治疗服务。该研究将研究综合（EAP/MBHC）和独立组件产品之间对滥用药物的利用，成本和参与性的看法存在差异。具体问题包括：注册者或产品特征的途径选择是否存在差异；利用模式和成本的不同，取决于路径或产品结构；这似乎有助于早期干预；在潜在的帮助资源方面，参与者认为哪些障碍；护理经验如何因途径而有所不同；参与性的意识和对服务的看法如何影响使用服务的意愿；以及MBHC和EAP服务是否起作用或补充作用。这项研究的结果将引起雇主，保险公司和政策制定者的塑造，因为它们塑造了影响获得护理机会的政策。